Shop Detailed

Descriptions

RETATRUTIDE 3ml

Retatrutide is an investigational triple-agonist peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. This unique mechanism makes it a subject of intense research interest in the fields of obesity, metabolic syndrome, and type 2 diabetes.

Key Research Highlights

• A1C Lowering: Retatrutide powerfully lowers blood glucose levels.
• Diabetes Remission: Many type 2 diabetes patients achieved normal blood sugar (HbA1c < 5.7%) while taking the peptide.
• Metabolism & Fat Loss: Studied for potent effects on body weight and energy expenditure
• Liver Fat Reduction: Because the glucagon component specifically targets fat clearance in the liver, retatrutide cleared up to 80% or more of excess liver fat in patients with non-alcoholic fatty liver disease during trials.
• Lipid Profile: It significantly improves cholesterol levels, specifically lowering triglycerides and LDL ("bad") cholesterol
• High purity ≥99% verified by third-party HPLC

Specifications

For laboratory research purposes only. Not for human consumption.